NCT00741611

Study of HD Mesh Ablation System for Treatment of Paroxysmal Atrial Fibrillation

A Randomized Controlled Trial of Radiofrequency Ablation for the Treatment of Paroxysmal Atrial Fibrillation Using the Bard High Density Mesh Ablation System (MAGELLAN)

• Status: Terminated
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 44 (actual)
• Sponsor: C. R. Bard · Industry
• Sex: All
• Age: 21 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

This is a randomized controlled study of the Bard High Density Mesh Ablation System for treatment of paroxysmal atrial fibrillation. This study will determine if the HD Mesh Ablation System is as safe as and more effective than anti-arrhythmic drugs.

Conditions

• Paroxysmal Atrial Fibrillation

Interventions

Type	Name	Description
DEVICE	HD Mesh Ablation System	Ablation using the HD Mesh Ablation System
DRUG	Anti-arrhythmic drugs	5 anti-arrhythmic drugs administered at the labeled dosage for atrial fibrillation

Timeline

• Start date: 2008-07-01
• Primary completion: 2009-11-01
• Completion: 2009-11-01
• First posted: 2008-08-26
• Last updated: 2012-10-26
• Results posted: 2012-10-26

Locations

13 sites across 1 country: United States